| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1055/S-2004-831051 |
| P8608 | Fatcat ID | release_flsob5syyfgknfbuge24wu7o4u |
| P698 | PubMed publication ID | 15282661 |
| P2093 | author name string | Andreas Bikfalvi | |
| P433 | issue | 3 | |
| P304 | page(s) | 379-385 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Seminars in Thrombosis and Hemostasis | Q15751825 |
| P1476 | title | Platelet factor 4: an inhibitor of angiogenesis | |
| P478 | volume | 30 |
| Q80228171 | A new role for NF-kappaB in angiogenesis inhibition |
| Q47233830 | Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors. |
| Q37781665 | Angiogenesis as a therapeutic target in urothelial carcinoma |
| Q38757723 | Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility |
| Q61816784 | Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives |
| Q37900334 | Cattle and chemokines: evidence for species-specific evolution of the bovine chemokine system. |
| Q47559793 | Cellular and Molecular Changes in MNU-Induced Breast Tumours Injected with PF4 or bFGF |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q41444120 | Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. |
| Q45857995 | Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma |
| Q42099455 | Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice |
| Q92403252 | Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model |
| Q35088245 | Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina |
| Q36489766 | Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey |
| Q37294970 | Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide |
| Q89183243 | GIFT: Guided and Interpretable Factorization for Tensors with an application to large-scale multi-platform cancer analysis |
| Q33927042 | Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuli |
| Q37634740 | Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model. |
| Q38826454 | Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis |
| Q33480555 | Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data |
| Q36414904 | Low-molecular-weight heparins and angiogenesis |
| Q61809077 | Lymph Node Lymphatic Endothelial Cell Expansion and Contraction and the Programming of the Immune Response |
| Q37088045 | NF-kappa B: a new player in angiostatic therapy |
| Q26781297 | Novel endogenous angiogenesis inhibitors and their therapeutic potential |
| Q40219504 | Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. |
| Q33588814 | Phosphatase inhibitors with anti-angiogenic effect in vitro |
| Q39698792 | Pigment epithelium-derived factor (PEDF): a novel trophoblast-derived factor limiting feto-placental angiogenesis in late pregnancy. |
| Q38674677 | Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. |
| Q53589389 | Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin. |
| Q33573493 | Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria |
| Q36841086 | Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation |
| Q91870457 | Platelets and Platelet-Derived Extracellular Vesicles in Liver Physiology and Disease |
| Q48621436 | Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II. |
| Q89963380 | Proteomic insights on the metabolism in inflammatory bowel disease |
| Q28395110 | Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica |
| Q36120825 | Role of chemokines in tumor growth |
| Q28294538 | Roles of platelet factor 4 in hematopoiesis and angiogenesis |
| Q50932310 | The Role of Angiogenesis in Cancer Treatment. |
| Q30159968 | The anti-angiogenic peptide anginex disrupts the cell membrane |
| Q36793120 | The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity. |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q33803558 | The role of platelets in tumour growth |
| Q38974266 | Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. |
| Q37743207 | Tumor angiogenesis: insights and innovations |
| Q59941220 | Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response |
| Q36128546 | Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet Hyperreactivity |
Search more.